Literature DB >> 33159308

Use of Raman spectroscopy to evaluate the biochemical composition of normal and tumoral human brain tissues for diagnosis.

Ricardo Pinto Aguiar1, Edgar Teixeira Falcão2, Carlos Augusto Pasqualucci3, Landulfo Silveira4.   

Abstract

Raman spectroscopy was used to identify biochemical differences in normal brain tissue (cerebellum and meninges) compared to tumors (glioblastoma, medulloblastoma, schwannoma, and meningioma) through biochemical information obtained from the samples. A total of 263 spectra were obtained from fragments of the normal cerebellum (65), normal meninges (69), glioblastoma (28), schwannoma (8), medulloblastoma (19), and meningioma (74), which were collected using the dispersive Raman spectrometer (830 nm, near infrared, output power of 350 mW, 20 s exposure time to obtain the spectra), coupled to a Raman probe. A spectral model based on least squares fitting was developed to estimate the biochemical concentration of 16 biochemical compounds present in brain tissue, among those that most characterized brain tissue spectra, such as linolenic acid, triolein, cholesterol, sphingomyelin, phosphatidylcholine, β-carotene, collagen, phenylalanine, DNA, glucose, and blood. From the biochemical information, the classification of the spectra in the normal and tumor groups was conducted according to the type of brain tumor and corresponding normal tissue. The classification used in discrimination models were (a) the concentrations of the biochemical constituents of the brain, through linear discriminant analysis (LDA), and (b) the tissue spectra, through the discrimination by partial least squares (PLS-DA) regression. The models obtained 93.3% discrimination accuracy through the LDA between the normal and tumor groups of the cerebellum separated according to the concentration of biochemical constituents and 94.1% in the discrimination by PLS-DA using the whole spectrum. The results obtained demonstrated that the Raman technique is a promising tool to differentiate concentrations of biochemical compounds present in brain tissues, both normal and tumor. The concentrations estimated by the biochemical model and all the information contained in the Raman spectra were both able to classify the pathological groups.
© 2020. Springer-Verlag London Ltd., part of Springer Nature.

Entities:  

Keywords:  Biochemical analysis; Brain tumors; Diagnosis; Raman spectroscopy

Mesh:

Year:  2020        PMID: 33159308     DOI: 10.1007/s10103-020-03173-1

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  30 in total

Review 1.  Prospects for in vivo Raman spectroscopy.

Authors:  E B Hanlon; R Manoharan; T W Koo; K E Shafer; J T Motz; M Fitzmaurice; J R Kramer; I Itzkan; R R Dasari; M S Feld
Journal:  Phys Med Biol       Date:  2000-02       Impact factor: 3.609

2.  Profiling differences in chemical composition of brain structures using Raman spectroscopy.

Authors:  Marko Daković; Aleksandra S Stojiljković; Danica Bajuk-Bogdanović; Ana Starčević; Laslo Puškaš; Branislav Filipović; Snežana Uskoković-Marković; Ivanka Holclajtner-Antunović
Journal:  Talanta       Date:  2013-09-06       Impact factor: 6.057

3.  Discriminating model for diagnosis of basal cell carcinoma and melanoma in vitro based on the Raman spectra of selected biochemicals.

Authors:  Landulfo Silveira; Fabrício Luiz Silveira; Benito Bodanese; Renato Amaro Zângaro; Marcos Tadeu T Pacheco
Journal:  J Biomed Opt       Date:  2012-07       Impact factor: 3.170

4.  Discrimination of prostate carcinoma from benign prostate tissue fragments in vitro by estimating the gross biochemical alterations through Raman spectroscopy.

Authors:  Landulfo Silveira; Kátia Ramos M Leite; Fabricio Luiz Silveira; Miguel Srougi; Marcos Tadeu T Pacheco; Renato Amaro Zângaro; Carlos Augusto Pasqualucci
Journal:  Lasers Med Sci       Date:  2014-03-12       Impact factor: 3.161

5.  Determination of human coronary artery composition by Raman spectroscopy.

Authors:  J F Brennan; T J Römer; R S Lees; A M Tercyak; J R Kramer; M S Feld
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

6.  Near infrared Raman spectra of human brain lipids.

Authors:  Christoph Krafft; Lars Neudert; Thomas Simat; Reiner Salzer
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2005-05       Impact factor: 4.098

7.  Quantification of brain lipids by FTIR spectroscopy and partial least squares regression.

Authors:  Isabell Dreissig; Susanne Machill; Reiner Salzer; Christoph Krafft
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2008-08-28       Impact factor: 4.098

8.  Towards the intra-operative use of Raman spectroscopy in breast cancer-overcoming the effects of theatre lighting.

Authors:  Jonathan D Horsnell; Catherine Kendall; Nicholas Stone
Journal:  Lasers Med Sci       Date:  2016-05-25       Impact factor: 3.161

9.  Raman spectral feature selection using ant colony optimization for breast cancer diagnosis.

Authors:  Omid Fallahzadeh; Zohreh Dehghani-Bidgoli; Mohammad Assarian
Journal:  Lasers Med Sci       Date:  2018-06-04       Impact factor: 3.161

10.  The use of Raman spectroscopy to provide an estimation of the gross biochemistry associated with urological pathologies.

Authors:  Nicholas Stone; Maria Consuelo Hart Prieto; Paul Crow; Jeremy Uff; Alistair William Ritchie
Journal:  Anal Bioanal Chem       Date:  2006-11-23       Impact factor: 4.142

View more
  1 in total

Review 1.  Use of advanced neuroimaging and artificial intelligence in meningiomas.

Authors:  Norbert Galldiks; Frank Angenstein; Jan-Michael Werner; Elena K Bauer; Robin Gutsche; Gereon R Fink; Karl-Josef Langen; Philipp Lohmann
Journal:  Brain Pathol       Date:  2022-03       Impact factor: 6.508

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.